Lifeway Foods, Inc. (LWAY) - Q3 2025 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended September 30, 2025. Lifeway Foods, Inc. is the largest producer and marketer of kefir in the U.S., operating as a single reportable segment. The company manufactures and distributes cultured dairy products, including drinkable kefir, European-style soft cheeses, and drinkable yogurt, primarily within the United States.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Net Sales | $57.14 million | $46.10 million | $157.14 million | $139.89 million |
| Gross Profit | $16.41 million (28.7%) | $11.87 million (25.7%) | $42.84 million (27.3%) | $36.68 million (26.2%) |
| Operating Income | $5.04 million | $4.19 million | $12.41 million | $13.14 million |
| Net Income | $3.53 million | $2.98 million | $11.32 million | $9.19 million |
| Diluted EPS | $0.23 | $0.19 | $0.74 | $0.60 |
| Cash & Equivalents | $22.99 million (as of Sept 30, 2025) | |||
| Operating Cash Flow (YTD) | $10.68 million (2025) vs $15.54 million (2024) | |||
| Debt | $0 outstanding; $25.0 million available on Revolver |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 24.0% in Q3 and 12.3% YTD compared to the prior year. On a comparable basis (adjusting for a strategic customer exit and distributor logistics changes in 2024), sales growth was approximately 29% in Q3 and 19% YTD.
- Margin Expansion: Gross margin improved to 28.7% in Q3 (from 25.7% in 2024) and 27.3% YTD (from 26.2% in 2024), driven by manufacturing efficiencies from higher volumes and favorable conventional milk pricing.
- Expense Increases: General and Administrative (G&A) expenses rose significantly ($2.62 million in Q3; $3.69 million YTD) due to approximately $2.4 million (Q3) and $4.3 million (YTD) in professional fees related to an unsolicited purchase proposal from Danone and non-routine stockholder actions.
- Investment Gain: YTD 2025 results include a one-time gain of $3.41 million from the sale of the company's equity investment in Simple Mills.
Outlook, Risks, and Unusual Items
- Capital Projects: The company is expanding its Waukesha, Wisconsin facility to double manufacturing capacity. Total estimated investment is $45 million, with completion expected in Q4 2026. Approximately $9.2 million is capitalized on the balance sheet as of September 30, 2025.
- Supply Chain Strategy: To secure organic milk supply, the company purchased 402 mature dairy cows in Q3 2025 for $1.34 million and entered a 60-month "Herd Agreement" with a third-party dairy facility.
- Liquidity: The company maintains a strong liquidity position with $22.99 million in cash and a $25 million revolving credit facility with no outstanding borrowings. It is in compliance with all debt covenants.
- Risks: Management cites risks related to commodity pricing, supply chain disruptions, and macroeconomic conditions. The filing notes no material changes to risk factors from the 2024 10-K.
- Shareholder Rights: The Shareholder Rights Plan (poison pill) was amended in October 2025 to extend its expiration date to October 29, 2026.
Investor Verification Checklist
- Verify the sustainability of the 29% comparable sales growth rate in Q3 2025.
- Monitor the impact of the $45 million Waukesha facility expansion on future capital expenditures and cash flow.
- Assess the long-term cost implications of the new organic milk herd agreement versus market pricing.
- Review the status of the Danone unsolicited proposal and associated professional fees to determine if they are recurring.
- Confirm the company's ability to maintain gross margins given potential volatility in organic milk pricing.